Erythema Nodosum in Crohn's Disease: A Patient Guide

If you have noticed painful, tender bumps on your shins that bruise and linger, you may be dealing with erythema nodosum - the most common skin manifestation of Crohn's disease. Many of us living with Crohn's focus entirely on what is happening inside the gut, so a flare that shows up on the skin can feel confusing and even alarming. Understanding why these nodules appear, what they signal about your underlying disease, and how they are treated can help you advocate for the right care at the right time.

This guide breaks down the evidence on erythema nodosum in Crohn's disease, including a 2026 study that reframes these skin lesions as a meaningful marker of active intestinal inflammation - not just a rash to ice and elevate.

Key Takeaways

• Erythema nodosum (EN) affects roughly 5-15% of Crohn's disease patients and is the most common cutaneous manifestation of IBD (1, 2).
• A 2026 study of 95 IBD patients with EN found that 84% had active endoscopic disease and 75% had elevated CRP at the time of the skin flare (4).
• EN most often appears as tender red-to-purple nodules on the anterior shins, typically in women aged 20 to 30, and heals without scarring (2, 5).
• The appearance of EN should prompt reassessment of your Crohn's disease activity - not just topical or symptomatic skin care (4).
• Treatment focuses on controlling the underlying Crohn's disease; anti-TNF therapy such as infliximab shows response rates of about 80% in refractory cases (1).

What Is Erythema Nodosum and Why Crohn's Patients Get It

Erythema nodosum is an inflammation of the fat layer just beneath the skin - a condition doctors call panniculitis - that produces tender, red-to-purple nodules. It is the most common skin manifestation of inflammatory bowel disease, and understanding the immune mechanism behind it helps explain why Crohn's patients are particularly vulnerable (1, 2).

The immune reaction behind the nodules

On biopsy, erythema nodosum shows a pattern called septal panniculitis without vasculitis - meaning inflammation runs along the connective tissue walls between fat lobules, without directly attacking blood vessels (2). Researchers believe this is driven by a type IV hypersensitivity reaction, with a Th1-polarized immune response and elevated levels of interferon-gamma (IFN-gamma) and interleukin-12 (IL-12) (1). In simpler terms, your immune system overreacts in the fat tissue under the skin, producing painful lumps.

Why Crohn's disease raises the risk

Crohn's disease is itself driven by Th1-type immune activity, so the overlap is not accidental. The chronic gut inflammation and immune dysregulation that define Crohn's can trigger the same inflammatory cascade in the skin as an extraintestinal manifestation (1). If you have read about how Crohn's connects to other autoimmune conditions, erythema nodosum fits squarely into that pattern - the same overactive immune system causing trouble in a different organ.

How Common Is Erythema Nodosum in Crohn's Disease

Erythema nodosum affects roughly 5-15% of people with Crohn's disease, depending on the study population and how rigorously cases are tracked (1, 2). While that might sound like a small minority, it makes EN the single most common skin manifestation of IBD - far more frequent than pyoderma gangrenosum, its more severe cousin.

Prevalence in Crohn's versus ulcerative colitis

In a well-known cohort study of 2,402 IBD patients, erythema nodosum occurred in 4.0% overall and was significantly and independently associated with a Crohn's disease diagnosis, female sex, and the presence of eye and joint involvement (3). Crohn's patients develop EN more often than those with ulcerative colitis, likely because of the stronger Th1 immune drive in Crohn's disease.

Who is at highest risk

Women aged 20 to 30 are the most commonly affected group (2, 5). Fewer than 15% of patients develop erythema nodosum before their IBD is diagnosed; in most cases, EN appears during or after Crohn's disease is already established (1). If you have other extraintestinal manifestations - particularly joint pain or eye inflammation - your risk of developing EN is higher (3).

Recognizing the Signs: Symptoms, Location, and Duration

Erythema nodosum has a distinctive appearance and pattern that most gastroenterologists and dermatologists can recognize on sight. Knowing what to look for can help you report the problem early, before it delays the more important question: is your Crohn's disease flaring?

What the nodules look and feel like

The hallmark of EN is tender, warm, red-to-purple nodules, typically 1-5 centimeters in diameter. They appear most often on the anterior shins - the front of the lower legs - but can also show up on the calves, thighs, ankles, forearms, or trunk (2, 5). They feel firm and painful to the touch, and pressing on them hurts. Unlike some other skin conditions, the skin over the nodules stays intact - there is no ulceration or open wound.

Associated systemic symptoms

EN rarely arrives alone. Many patients report low-grade fever, fatigue, malaise, and joint pain at the same time the nodules appear (5). These systemic symptoms can overlap with a Crohn's flare, which is exactly the point - EN often coincides with active intestinal disease.

How lesions evolve and heal

One reassuring fact: erythema nodosum heals without scarring. Over days to weeks, the nodules change color from red-purple to brown, going through the same sequence as a deep bruise (2, 5). Individual episodes generally last weeks to months and can recur throughout life, especially when the underlying Crohn's disease is not well controlled (5).

Erythema Nodosum as a Marker of Active Crohn's Disease

Here is where erythema nodosum stops being "just a skin problem." Most patient-facing resources treat EN as a rash to cool, elevate, and wait out. But a growing body of evidence - including a 2026 study - suggests that EN is a meaningful clinical signal of active intestinal inflammation.

New 2026 evidence linking EN to endoscopic activity

A 2026 single-center study by Sasson and colleagues examined 95 IBD patients who developed erythema nodosum and found striking results: 84% had active endoscopic disease, 75% had elevated C-reactive protein (CRP), and 73% had elevated fecal calprotectin (4). Even more telling, 74% of patients reported gastrointestinal symptoms at the time their EN appeared (4). These numbers make a strong case that EN is not an isolated skin event but a surface-level signal of deeper trouble.

For context, fecal calprotectin is one of the most reliable non-invasive markers of intestinal inflammation. If you are unfamiliar with it, our fecal calprotectin guide explains how the test works and what the numbers mean.

What to ask your gastroenterologist when EN appears

The Sasson et al. findings support a practical shift: the appearance of EN should trigger objective reassessment of your IBD activity - not just symptomatic skin care (4). If you develop tender leg nodules, consider asking your gastroenterologist:

• Can we check CRP and fecal calprotectin to assess intestinal inflammation?
• Should we consider a colonoscopy or imaging to look at disease activity directly?
• Is my current treatment adequately controlling my Crohn's, or does this EN episode suggest we need to adjust?

Erythema nodosum often parallels intestinal flares, so its appearance is a signal to review treatment adequacy, not to simply wait it out (2).

How Doctors Diagnose Erythema Nodosum

In most cases, diagnosis is straightforward - erythema nodosum has a classic look and location that experienced clinicians recognize without specialized testing (2). But the diagnostic process also involves figuring out why the EN appeared, which matters especially for Crohn's patients.

Physical examination and history

Diagnosis is usually clinical, based on the classic distribution of tender nodules on the shins and the patient's medical history (2). Your doctor will look at the size, location, color, and tenderness of the nodules. Having a known Crohn's diagnosis makes the connection to IBD the leading explanation, but your doctor should still consider the timing and context.

When a biopsy is needed

A skin biopsy is seldom required but can be useful when the presentation is atypical or when doctors need to differentiate EN from metastatic cutaneous Crohn's disease or other panniculitides (2). Metastatic cutaneous Crohn's is a separate condition where granulomas - the same microscopic structures found in the intestine - appear in the skin. It is rarer than EN and requires a different treatment approach.

Blood work and IBD activity assessment

Beyond the skin diagnosis, providers should rule out other triggers such as streptococcal infection, tuberculosis, sarcoidosis, pregnancy, and offending medications (5). A systematic review noted marked inconsistency in how studies diagnosed IBD-associated EN and recommended a multidisciplinary approach combining gastroenterology, dermatology, and rheumatology expertise for complex cases (6). Blood work including CRP, ESR, and fecal calprotectin helps quantify the degree of underlying Crohn's activity.

Evidence-Based Treatment for Erythema Nodosum in Crohn's

The most important thing to understand about treating erythema nodosum in Crohn's disease is that the skin is not the primary target - the gut is. EN tends to resolve when the underlying intestinal disease is brought under control (2).

Treating the underlying IBD as the foundation

The primary treatment is optimizing control of your Crohn's disease. When intestinal inflammation is reduced, erythema nodosum episodes typically improve or resolve on their own (2). This means working with your gastroenterologist to ensure your current therapy - whether it is a biologic, immunomodulator, or combination - is achieving adequate disease control. If EN keeps returning, it may be a sign that your current regimen is not enough.

Supportive care that actually helps

While waiting for IBD treatment to take effect, supportive measures can ease the discomfort. These include rest, leg elevation, compression stockings, and pain control with acetaminophen or NSAIDs - though NSAIDs should be used cautiously in Crohn's since they can worsen intestinal inflammation in some patients (2, 5). Cool compresses on the affected areas can provide temporary relief.

When systemic steroids and biologics are needed

For severe or refractory cases, systemic corticosteroids at 0.5 to 1 mg/kg per day are often initiated to bring the inflammation under control quickly (2). This is typically a short-term bridge while longer-acting therapies take effect.

Anti-TNF agents such as infliximab show response rates of about 80% in refractory erythema nodosum and are commonly used when EN is related to anti-TNF-responsive Crohn's disease (1). If you are already on an anti-TNF medication like adalimumab and still developing EN, your gastroenterologist may need to check drug levels or consider switching to a different biologic class. Ustekinumab has also been reported to help both Crohn's disease and coexisting erythema nodosum in case reports, offering another option for patients who do not respond to anti-TNF therapy (1).

When to Call the Gastroenterologist Versus the Dermatologist

One practical question that comes up often: if you develop tender leg nodules, who do you call first?

Call your gastroenterologist first if you have known Crohn's disease, especially if the skin lesions appear alongside worsening GI symptoms like diarrhea, abdominal pain, or bloody stools. The 2026 data showing that 84% of EN patients had active endoscopic disease makes a strong case for treating this as a Crohn's signal first and a skin issue second (4).

See a dermatologist if the diagnosis is uncertain, if the nodules look atypical, or if your gastroenterologist wants a biopsy to rule out metastatic cutaneous Crohn's disease or another panniculitis. In complex cases, the best outcomes come from a collaborative approach between gastroenterology and dermatology (6).

Frequently Asked Questions

Is erythema nodosum dangerous?

Erythema nodosum itself is not dangerous - it heals without scarring and does not damage internal organs. However, its significance lies in what it signals. In Crohn's disease, EN often indicates active intestinal inflammation that may need treatment adjustment (4). The nodules are painful and can affect quality of life, but the skin condition itself is self-limiting.

Can erythema nodosum appear before a Crohn's diagnosis?

Yes, though it is uncommon. Fewer than 15% of patients develop erythema nodosum before their IBD is diagnosed (1). If you develop unexplained tender nodules on your shins and have not been evaluated for IBD, it is worth mentioning to your doctor - especially if you also have chronic diarrhea, abdominal pain, or unexplained weight loss.

How long does an erythema nodosum episode last?

Individual episodes typically last weeks to months. The nodules go through a bruise-like color change from red-purple to brown before fading (2, 5). Recurrence is common if the underlying Crohn's disease is not well controlled. With effective IBD treatment, episodes become less frequent and may stop entirely.

Does erythema nodosum mean my Crohn's treatment is failing?

Not necessarily, but it should prompt a conversation with your gastroenterologist. The 2026 Sasson et al. study found that the majority of EN patients had active endoscopic disease, suggesting that current treatment may need reassessment (4). Think of EN as an early warning system - it is your body signaling that intestinal inflammation may be more active than you realize.

Can I treat erythema nodosum with creams or topical steroids?

Topical treatments have limited effectiveness for erythema nodosum because the inflammation sits deep in the fat layer beneath the skin, not on the surface (2). Supportive measures like rest, leg elevation, cool compresses, and compression stockings are more helpful. The definitive treatment is controlling the underlying Crohn's disease.

Is erythema nodosum the same as pyoderma gangrenosum?

No. While both are skin manifestations of IBD, they are very different conditions. Erythema nodosum produces tender, intact nodules that heal without scarring. Pyoderma gangrenosum causes deep, painful ulcers with undermined borders that can scar significantly. Pyoderma gangrenosum is rarer and often requires more aggressive treatment (1, 2).

Should I worry about erythema nodosum during pregnancy?

Pregnancy itself can trigger erythema nodosum, even in people without IBD (5). For pregnant Crohn's patients, the appearance of EN adds complexity because both the EN and any underlying Crohn's flare need to be managed with pregnancy-safe medications. Work closely with both your gastroenterologist and obstetrician to balance disease control with fetal safety.

References

1. He R, Zhao S, Cui M, Chen Y, Ma J, Li J, Wang X. Cutaneous manifestations of inflammatory bowel disease: basic characteristics, therapy, and potential pathophysiological associations. Frontiers in Immunology, 2023. Read study
2. Bernett CN, Krishnamurthy K. Cutaneous Crohn Disease. StatPearls Publishing, updated January 9, 2023. Read article
3. Farhi D, Cosnes J, Zizi N, Chosidow O, Seksik P, Beaugerie L, Aractingi S, Khosrotehrani K. Significance of erythema nodosum and pyoderma gangrenosum in inflammatory bowel diseases: a cohort study of 2402 patients. Medicine (Baltimore), 2008; 87(5):281-293. View on PubMed
4. Sasson S, Kalisky I, Rosenfeld G, Liu Chen Kiow J, Bressler B. Erythema nodosum as a marker for objective disease activity in inflammatory bowel disease. Crohn's & Colitis 360, February 2026; 8(1):otag013. Read study
5. Cleveland Clinic. Erythema Nodosum: Symptoms, Causes and Treatment. 2024. Read article
6. Sharma R, Payne K, Qazi T, Rieder F, Falloon K. Diagnosis of Inflammatory Bowel Disease Associated Erythema Nodosum: A Systematic Review. Inflammatory Bowel Diseases, February 2025; 31(Supplement_1):S21. Read study